Matrix metalloproteinases: not-so-innocent bystanders in heart failure.
- 1 October 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (7) , 827-828
- https://doi.org/10.1172/JCI11263
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Disruption of the myocardial extracellular matrix leads to cardiac dysfunctionJournal of Clinical Investigation, 2000
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionJournal of Clinical Investigation, 2000
- Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic targetCardiovascular Research, 2000
- The role of the cytoskeleton in heart failureCardiovascular Research, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999
- Matrix Metalloproteinase Inhibition During the Development of Congestive Heart FailureCirculation Research, 1999
- Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth MuscleCell, 1999
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCirculation, 1999
- β 1 Integrins Participate in the Hypertrophic Response of Rat Ventricular MyocytesCirculation Research, 1998
- Extracellular Proteins Needed for C. elegans MechanosensationNeuron, 1996